Article info
PDFTest yourself
A patient with papilloedema
- Correspondence to Nicola Giffin, Neurology, Royal United Hospital Bath NHS Trust, Bath, UK, BA13NG;Nicola.giffin{at}nhs.net
Citation
A patient with papilloedema
Publication history
- Accepted August 20, 2020
- First published October 1, 2020.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
- Severe papilloedema with vision loss secondary to Guillain-Barré syndrome
- Rapidly progressive vision loss due to fulminant idiopathic intracranial hypertension: a diagnostic and management dilemma
- Drugs used in childhood idiopathic or benign intracranial hypertension
- Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients
- Iron deficiency masquerading as idiopathic intracranial hypertension
- Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension
- Chiari type 1 malformation in a pseudotumour cerebri patient: is it an acquired or congenital Chiari malformation?
- Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting
- Intracranial hypertension and papilloedema as a complication to low antiretroviral therapy adherence in a man living with chronic HIV